Estrogen inhibits adrenal angiotensin type 1 receptor (AT(1)R) binding sites and attenuates the adrenal responsivity to angiotensin II (Ang II). Ang II modulates AT(1)R expression. Here, we determined if estrogen-induced down-regulation of adrenal AT(1)Rs involves modulation of adrenal Ang II. Female rats were ovariectomized (OVX) and injected with 17beta-estradiol benzoate (E(2); 40 micro g/kg) or vehicle for 7 d. Adrenal Ang II was separated from other angiotensin peptides by HPLC and measured by RIA. Scatchard analysis of radioligand binding curves showed that E(2) or captopril (Cap; 0.5 g/liter water) significantly reduced adrenal AT(1)R binding (maximum binding capacity) by 22% and 19%, respectively, compared with OVX (276 +/- 2.09 fmol/mg protein). E(2) and Cap lowered adrenal Ang II levels by 39% and 21%, respectively, compared with OVX (4.10 +/- 0.44 pmol/g). E(2) caused no further reductions in adrenal AT(1)R binding or in Ang II levels in Cap-treated OVX rats. High-dose Ang II infusion (1000 ng/kg.min) increased adrenal Ang II levels by 71% and lowered AT(1)R binding by 18%. Under these infusion conditions, E(2) did not reduce adrenal Ang II or AT(1)R binding. No differences in AT(1)R affinity (dissociation constant) were observed among groups. These data suggest that E(2) regulates the number of adrenal AT(1)R binding sites indirectly by modulating adrenal Ang II.

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2002-221100DOI Listing

Publication Analysis

Top Keywords

at1r binding
24
adrenal ang
24
adrenal
14
adrenal angiotensin
12
adrenal at1r
12
ang levels
12
ang
10
angiotensin type
8
modulating adrenal
8
at1r
8

Similar Publications

Objective: Systemic sclerosis (SSc) is a rare but severe autoimmune disease characterized by immune dysregulation, fibrosis, and vasculopathy. While previous studies have highlighted the presence of functional autoantibodies targeting the angiotensin II type 1 receptor (ATR) and endothelin-1 type A receptor (ETR), leading to autoantibody-mediated receptor stimulation and subsequent activation of endothelial cells (ECs), a comprehensive understanding of the direct interaction between these autoantibodies and their receptors is currently lacking. Moreover, existing data confirming the presence of these autoantibodies in SSc often rely on similar methodologies and assays.

View Article and Find Full Text PDF
Article Synopsis
  • Angiotensin II (Ang II) is crucial for blood pressure regulation, and a modified version called pyruvamide-Ang II (Ang P), created with a cheaper vitamin B derivative (pyridoxal-5'-phosphate), may provide a cost-effective treatment for hypertension.
  • Studies showed that Ang P leads to lower calcium entry in vascular smooth muscle cells and has a weaker binding affinity to the angiotensin II type 1 receptor, resulting in less vasoconstriction compared to traditional Ang II.
  • In tests on rats, using PLP significantly reduced blood pressure in spontaneously hypertensive rats and prevented blood pressure spikes in normal rats when treated with both Ang II and PLP, suggesting
View Article and Find Full Text PDF

Potential of CME@ZIF-8 MOF Nanoformulation: Smart Delivery of Silymarin for Enhanced Performance and Mechanism in Albino Rats.

ACS Appl Bio Mater

October 2024

Department of Biotechnology, The Institute of Biochemistry, Biotechnology and Bioinformatics, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan.

Article Synopsis
  • The study developed a drug delivery system using plant extract-coated zeolitic imidazole frameworks (CME@ZIF-8) to enhance silymarin's solubility and bioavailability, demonstrating its protective effects against nephrotoxicity and cardiac toxicity in rats exposed to carbon tetrachloride (CCl).
  • Analysis showed that the new PEG-Sily@CME@ZIF-8 formulation improved antioxidant defenses and reduced damage in the rats, with mechanisms identified through interactions with various proteins related to cellular health.
View Article and Find Full Text PDF

The Relationship among SARS-CoV-2, Vaccine Spike Protein, Renin- Angiotensin System, and Epilepsy.

Infect Disord Drug Targets

September 2024

Faculty of Medicine, CNRS, INP, Inst Neurophysiopathol, Aix-Marseille University, 13385 Marseille, France.

Several comorbidities and illnesses have emerged after the COVID-19 pandemic and the introduction of vaccination based on a slightly modified SARS-CoV-2 spike protein. One of these diseases is epilepsy, where the dysfunctional RAS plays a crucial role in the propagation of the disorder. SARS-CoV-2 infects host cells by utilizing the angiotensin-converting enzyme Type 2 (ACE2) receptor, which allows the virus to infect various cell types, including those in the lungs, nasopharynx, kidneys, lymph nodes, small intestine, stomach, spleen, and brain, leading to widespread organ damage.

View Article and Find Full Text PDF

Background: Gestational diabetes can lead to increased blood pressure in offspring, accompanied by impaired renal sodium excretion function and vasoconstriction and diastole dysfunction. However, there are few studies on whether it is accompanied by increased sympathetic nerve activity.

Methods: Pregnant C57BL/6 mice were intraperitoneally injected with streptozotocin (35 mg/kg) or citrate buffer at day 0 of gestation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!